MoonLake Immunotherapeutics
Organization details
- Legal name
- MoonLake Immunotherapeutics
- Former names
- Helix Acquisition Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- ZUG
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MLTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001821586
Board of directors
-
Andrew John Phillips · DirectorSince 2023
-
Catherine Moukheibir · DirectorSince 2023
-
Da Silva Jorge Santos · Director · Chief Executive OfficerSince 2023
-
Mark N. Lampert · DirectorSince 2023
-
Ramnik Xavier · DirectorSince 2023
-
Simon Sturge · DirectorSince 2023
-
Spike Loy · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.4%
Board connections
3 of this board's directors also sit on 6 other boards. 6 are in the same sector.
-
Enliven Therapeutics Inc. Same sectorvia Andrew John Phillips
-
Immunic Inc. Same sectorvia Mark N. Lampert
-
Ironwood Pharmaceuticals Inc. Same sectorvia Catherine Moukheibir
-
Kymera Therapeutics Inc. Same sectorvia Mark N. Lampert
-
Olema Pharmaceuticals Inc. Same sectorvia Mark N. Lampert
-
OnKure Therapeutics Inc. Same sectorvia Andrew John Phillips
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $83,026,619
- 27 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −1,100 | $20.00 | $22,000 |
| Jul 22, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −2,448 | $20.00 | $48,960 |
| Jul 21, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −50,000 | $20.02 | $1,001,000 |
| Jul 20, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −43,700 | $20.09 | $877,933 |
| Jul 15, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −16,105 | $20.01 | $322,261 |
| Jul 10, 2026 | Da Silva Jorge Santos Director, Officer (Chief Executive Officer) | Open-market sale | −68,289 | $20.02 | $1,367,146 |
| Jul 9, 2026 | Da Silva Jorge Santos Director, Officer (Chief Executive Officer) | Open-market sale | −33,936 | $20.01 | $679,059 |
| Jul 1, 2026 | Da Silva Jorge Santos Director, Officer (Chief Executive Officer) | Open-market sale | −47,775 | $20.03 | $956,933 |
| Jun 22, 2026 | Bodenstedt Matthias Officer (Chief Financial Officer) | Open-market sale | −39,120 | $22.04 | $862,205 |
| Jun 18, 2026 | Bodenstedt Matthias Officer (Chief Financial Officer) | Open-market sale | −2,794 | $19.60 | $54,762 |
| Jun 17, 2026 | Bodenstedt Matthias Officer (Chief Financial Officer) | Open-market sale | −15,082 | $19.68 | $296,814 |
| Jun 17, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −50,000 | $19.43 | $971,500 |
| Jun 16, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −50,000 | $18.70 | $935,000 |
| Jun 15, 2026 | Reich Kristian Officer (Chief Scientific Officer) | Open-market sale | −50,000 | $18.89 | $944,500 |
| May 11, 2026 | Bodenstedt Matthias Officer (Chief Financial Officer) | Open-market sale | −13,653 | $20.02 | $273,333 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MoonLake Immunotherapeutics
Who is the CEO of MoonLake Immunotherapeutics?
Da Silva Jorge Santos is MoonLake Immunotherapeutics's Chief Executive Officer.
How many directors are on MoonLake Immunotherapeutics's board?
MoonLake Immunotherapeutics's board has 7 directors: Andrew John Phillips, Catherine Moukheibir, Da Silva Jorge Santos, Mark N. Lampert, Ramnik Xavier, Simon Sturge and Spike Loy.
Are MoonLake Immunotherapeutics insiders buying or selling shares?
Over the last 12 months, MoonLake Immunotherapeutics insiders made no open-market purchases and sold $83.0 million of shares in 27 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="moonlake-immunotherapeutics"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.